Moisturizing Lotion | Market Size, Share & Growth Report 2025-2033
The Moisturizing Lotion Market Report is Segmented by Product Type (Body Lotion, Face Lotion, Hand Lotion, Baby Lotion, and Sunscreen Lotion), Application (Skin Care, Baby Care, Sun Care, and Others), Distribution Channel (Online Stores, Supermarkets/Hypermarkets, Specialty Stores, Drug Stores, and Others), Ingredient Type (Hyaluronic Acid, Shea Butter, Aloe Vera, Coconut Oil, and Vitamin E).
Moisturizing Lotion Market
Market Analysis
How the market stands today, and what is shaping it
The global moisturizing lotion market was estimated at approximately USD 38.5 billion in 2025 and is projected to reach around USD 58.64 billion by 2033, representing a CAGR of approximately 5.40% during 2025-2033, based on Core Market Research estimates. The market covers five lotion formats, body, face, hand, baby and sunscreen, built on shared emollient systems of glycerin, hyaluronic acid, shea butter and coconut oil, with differentiation supplied by proprietary actives such as Beiersdorf's Thiamidol and the ceramide systems behind CeraVe. Growth rests on daily moisturising being a maintenance habit that turns over continuously, on those named actives supporting premiums that commodity humectants do not, and on dermatologist and pharmacist recommendation converting shoppers to higher price points. The constraint is saturation in mature markets, with North American body lotion forecast to compound at only 3.10% to 2034. Competition splits by tier rather than by geography: L'Oreal S.A. leads the fast-growing dermocosmetic segment, Beiersdorf AG competes as a pure skin care business, and Unilever PLC, The Procter & Gamble Company and Kenvue Inc. carry more weight in slower mass channels. Europe is the largest region at USD 17.32 billion of body lotion revenue in 2024. L'Oreal's Dermatological Beauty division crossing EUR 7 billion that year marks where the category's value is moving.
Market Dynamics
Key market dynamics and their impact on the industry landscape
Market Drivers
- Daily moisturising is a maintenance habit rather than an occasional purchase, so the category turns over volume continuously rather than on replacement cycles. Unilever's Beauty and Wellbeing underlying sales grew 6.5% in 2024 split between 5.1% volume and 1.3% price, showing the growth came from units sold rather than from charging more.
- Proprietary actives layered onto standard emollient bases have given manufacturers something to defend. Beiersdorf's Luminous630 pigmentation range recorded 34% organic growth in 2024 and its Thiamidol line carried Eucerin past EUR 1 billion in brand sales, which unpatentable humectants such as glycerin could never support on their own.
- Sunscreen regulation underpins the daily moisturiser carrying a sun protection factor. The United States classifies sunscreen as an over-the-counter drug requiring monograph-compliant actives and Broad Spectrum SPF labelling, and the European Union restricts ultraviolet filters to a positive list. Both give an SPF claim a verified basis that a general moisturising claim lacks.
- Dermatologist and pharmacist recommendation moves shoppers to higher price points without the advertising spend a mass brand needs. L'Oreal's Dermatological Beauty division reached a reported 25.5% category share while growing 9.8% like-for-like in 2024, and La Roche-Posay rose to become the world's third largest skincare brand through that route.
- Commercial expansion is coming from brands scaling internationally rather than from new category entry. CeraVe brand sales crossed EUR 2 billion in 2024 on expansion into SAPMENA, China and Brazil, and Beiersdorf lifted company-wide sales 6.5% to a record EUR 9.9 billion with NIVEA brand sales up 9% to EUR 5.6 billion.
Market Challenges
- The largest regional market is close to saturation. North American body lotion revenue is forecast to grow at only a 3.10% CAGR to 2034, the slowest of the three measured regions. United States volume fell 3.5% at Kenvue in fiscal 2024, which shows the softness is in units bought rather than in pricing.
- Base formulations are commodities. Glycerin, hyaluronic acid, shea butter and coconut oil appear from private label to prestige, so two lotions can share almost identical humectant and occlusive systems. That leaves brand, sensory finish and channel rather than measurable performance to justify a price gap that can run to twenty times.
- Published measurements of this market disagree by more than an order of magnitude. Estimates for body lotion alone in 2024 range from about USD 12 billion to USD 141 billion, and one widely quoted series values body lotion at a level exceeding a quarter of all skin care spending, which company disclosures do not support.
- Regulatory divergence forces separate formulations for the same product. The United States approves sunscreen actives through an over-the-counter drug monograph while the European Union maintains a positive list of ultraviolet filters, so a sunscreen lotion sold in both regions is typically two different products with two registration paths.
- The mass and premium tiers have decoupled. The Procter & Gamble Company's Beauty segment net sales rose only 1% to USD 15.2 billion in fiscal 2024 while L'Oreal's Dermatological Beauty division grew 9.8% like-for-like, which leaves manufacturers whose volume sits in mass body lotion exposed to a slower-growing part of the category.
Opportunities
- Pigmentation management could become the category's main premium claim outside ageing. Beiersdorf's Thiamidol and Luminous630 lines recorded 34% organic growth in 2024, and the claim has potential to travel particularly well in Asia Pacific, Latin America and the Middle East where tone evenness ranks above wrinkle reduction.
- Barrier-repair products may expand the category rather than cannibalise it. Beiersdorf reported Aquaphor growing alongside Eucerin and NIVEA in the first quarter of 2025, and an occlusive ointment bought in addition to a daily lotion raises spending per household rather than redistributing it.
- The combined moisturiser and sun protection product could consolidate two purchases into one at a higher price. Because sunscreen actives are regulated under a drug monograph in the United States and a positive list in the European Union, the SPF claim carries verification that a moisturising claim does not.
- Dermocosmetic distribution has room to extend geographically. CeraVe's brand sales crossed EUR 2 billion largely through SAPMENA, China and Brazil, which suggests the pharmacy-led model that scaled in Europe could be replicated in markets where it is not yet established.
- Medical-adjacent dry skin management may open a channel separate from beauty retail. Eczema and diabetes-related xerosis are managed with emollients on clinical advice, and a lotion positioned for that use could be specified by a clinician rather than chosen on shelf.
Trends and Insights
Key market trends shaping the industry landscape
Dermocosmetics outgrow mass beauty
High impactShort-termPharmacy-led, dermatologist-associated skin care is taking share from mass moisturiser brands across the major regions.
Insight: L'Oreal's Dermatological Beauty division grew 9.8% like-for-like in 2024 and crossed EUR 7 billion while The Procter & Gamble Company's Beauty segment grew 1%, which places the two tiers on visibly different trajectories.
Named actives replace base ingredients as the claim
High impactMid-termDifferentiation has moved from emollient systems to proprietary, trademarked active molecules layered onto them.
Insight: Thiamidol and Luminous630 carried Eucerin past EUR 1 billion in brand sales, which demonstrates that an ingredient a competitor cannot copy is what supports a premium in a category of shared commodity bases.
Sun protection merges into daily moisturising
Medium impactMid-termFacial lotions increasingly carry an SPF, so sun care and skin care are converging into a single daily product.
Insight: The convergence imports drug-grade regulation into a cosmetic category, since United States sunscreen actives sit under an over-the-counter monograph, which raises reformulation cost but also gives the claim external verification.
Growth relocates to Asia Pacific and Latin America
High impactLong-termCategory expansion is coming from markets establishing a daily moisturising habit rather than from mature markets replacing products.
Insight: Asia Pacific body lotion revenue of USD 15.17 billion in 2024 is forecast to compound at 5.20% against 3.10% in North America, and CeraVe named China and Brazil among its strongest new markets.
Volume rather than price carries growth
Medium impactShort-termRecent category growth has come from units sold instead of from price increases, reversing the pattern of the inflationary period.
Insight: Unilever's Beauty and Wellbeing underlying sales growth of 6.5% in 2024 split 5.1% volume against 1.3% price, which indicates pricing headroom in mass moisturisers is largely exhausted.
Segment Analysis
Market segmentation by product type, application, distribution channel, ingredient type
Body lotion is the largest of the five formats and the one that defines the category's price expectations, since it is bought in large volumes at low unit cost. Regional measurement supports its weight: body lotion revenue reached USD 17.32 billion in Europe, USD 15.17 billion in Asia Pacific and USD 10.49 billion in North America in 2024. Face lotion sits at a much higher price per millilitre and is where dermocosmetic positioning concentrates, with CeraVe crossing EUR 2 billion in brand sales and La Roche-Posay ranking as the third largest skincare brand worldwide. Sunscreen lotion is regulated differently from the rest, because in the United States sunscreen is an over-the-counter drug rather than a cosmetic, which changes labelling and active-ingredient approval. Baby lotion is a small but distinct format, valued at about USD 2.5 billion in 2024, and is formulated around fragrance and irritant restrictions rather than around performance claims. Hand lotion overlaps with hand cream, and the combined category was measured at USD 7.7 billion in 2024.
Geography Analysis
Regional market analysis
Asia Pacific
Asia Pacific is the fastest-growing region in this market. Body lotion revenue there reached USD 15.17 billion in 2024 and is forecast to grow at a 5.20% CAGR between 2025 and 2034, ahead of the 4.90% projected for Europe and the 3.10% for North America. Growth is driven by category creation rather than by replacement, since daily body moisturising is a newer habit across much of the region than it is in Europe. Climate shapes format preference toward light, fast-absorbing emulsions and away from heavy occlusive balms, and sun protection is bought for tone management as much as for burn prevention, which supports the combined moisturiser-plus-SPF product. CeraVe's expansion into China contributed to its brand sales crossing EUR 2 billion, and the SAPMENA territories were named among its strongest new markets. Japan and South Korea operate as mature premium markets within the region, with formulation standards that often lead rather than follow Western launches.
North America
North America is a large but slow-growing region and the one where the category is closest to saturation. Body lotion revenue was USD 10.49 billion in 2024 and is forecast to grow at only a 3.10% CAGR to USD 14.24 billion by 2034, the lowest regional rate. The regulatory position is distinctive: the United States treats sunscreen as an over-the-counter drug rather than a cosmetic, so sunscreen lotions require monograph-compliant actives and Broad Spectrum SPF labelling that differ from European rules. Demand softened in 2024, with Kenvue's Skin Health and Beauty segment net sales falling 3.2% to USD 4.2 billion on volume decreases of 3.5% concentrated in the United States. CeraVe's domestic advance in the same period shows the weakness was not uniform but concentrated in mass and legacy brands. The region remains the largest single market for dermatologist-recommended positioning.
Latin America
Latin America is a growth region for dermocosmetics rather than a mature mass market. Brazil is the principal market and was named among the strongest contributors to CeraVe brand sales crossing EUR 2 billion in 2024, alongside China and the SAPMENA territories. Climate and skin-tone distribution shape demand toward lightweight lotions and toward pigmentation management, which is the claim Beiersdorf's Thiamidol and Luminous630 lines address and which recorded 34% organic growth globally in 2024. Direct selling remains a significant route to market in Brazil and Mexico in a way it is not in Europe, so shelf presence understates the category's reach. Currency volatility and import duties raise the effective price of internationally formulated products, which sustains strong local and regional manufacturers alongside the global groups. No published figure isolates Latin American moisturising lotion revenue on its own, so the regional position rests on brand-level company disclosure.
Europe
Europe is the largest regional market. Body lotion revenue in Europe reached USD 17.32 billion in 2024, ahead of Asia Pacific at USD 15.17 billion and North America at USD 10.49 billion, and European revenue is forecast to grow at a 4.90% CAGR to USD 27.94 billion by 2034. The region is also where the category's leading suppliers are based and where the dermocosmetic model was built: Beiersdorf reported company-wide sales of EUR 9.9 billion in 2024 and L'Oreal's Dermatological Beauty division crossed EUR 7 billion. European Union cosmetic regulation requires a responsible person established in the Union and a product information file for each formulation, and it restricts ultraviolet filters to a positive list, which keeps European sunscreen lotions formulated differently from American ones. Pharmacy is a stronger channel here than in North America, which is the structural reason dermatologist-associated brands scaled in Europe first.
Middle East & Africa
The Middle East and Africa is the smallest of the five regions for this category and is usually reported inside residual groupings. Demand concentrates in the Gulf states and South Africa, with the Gulf supporting a premium market driven by high disposable income, intense sun exposure and constant air conditioning, all of which increase transepidermal water loss and the need for occlusive formulation. Pigmentation management is a leading claim across much of the territory, which aligns with the Thiamidol and Luminous630 lines that grew 34% organically in 2024. Halal certification constrains ingredient choice around alcohol content and animal-derived components for a substantial part of the customer base. African demand outside South Africa and the North African markets is served largely by lower-priced regional manufacturers and by petroleum-jelly-based products rather than by emulsion lotions. No published figure reports moisturising lotion revenue for this region separately.
Competitive Landscape
Key players and market positioning analysis
Five consumer goods groups account for most of the branded volume in this market, but they compete from different starting positions and with different exposure to the tier that is actually growing. Unilever PLC has the broadest reach in mass body lotion through Vaseline, Dove and Pond's, and its Beauty and Wellbeing division reported turnover of EUR 13 billion in 2024, up 5.5%, with skin care recording mid-single-digit growth. Its underlying growth split 5.1% volume against 1.3% price, which is the signature of a portfolio selling units rather than raising prices. Beiersdorf AG is the only one of the five that is essentially a pure skin care business, reporting company-wide sales of EUR 9.9 billion in 2024 and NIVEA brand sales of EUR 5.6 billion. It was named the best-performing skin care company globally for a second consecutive year. Its Eucerin brand passed EUR 1 billion for the first time on the strength of Thiamidol, which illustrates the company's strategy of owning named actives rather than competing on emollient bases. L'Oreal S.A. holds the strongest position in the fastest-growing tier, with a Dermatological Beauty division that grew 9.8% like-for-like in 2024, crossed EUR 7 billion and reported a 25.5% category share. La Roche-Posay is now the world's third largest skincare brand and CeraVe crossed EUR 2 billion in brand sales. The Procter & Gamble Company competes mainly through Olay, which generates approximately USD 3.6 billion in annual brand revenue, inside a Beauty segment that grew just 1% to USD 15.2 billion in fiscal 2024. Kenvue Inc. is the most exposed to the weak part of the market, with Skin Health and Beauty segment net sales down 3.2% to USD 4.2 billion. The competitive line therefore runs between companies whose weight sits in pharmacy-led dermocosmetics and those whose weight sits in supermarket body lotion, and in 2024 those two groups moved in opposite directions.
Major Players
Leading companies in the market
Industry Developments
7 recorded developments
Beiersdorf reported company-wide first-quarter 2025 sales above EUR 2.6 billion, with growth led by Eucerin and Aquaphor alongside NIVEA. Aquaphor is an occlusive ointment rather than a lotion, and its rise alongside lotions indicates buyers are adding barrier-repair products rather than substituting them for daily moisturisers.
Beiersdorf reported record company-wide sales of EUR 9.9 billion for 2024, 6.5% higher than 2023, and was named the best-performing skin care company globally for a second consecutive year. NIVEA brand sales rose 9% to EUR 5.6 billion, with the Luminous630 range recording 34% organic growth.
Eucerin passed EUR 1 billion in brand sales for the first time, becoming the second billion-euro brand in Beiersdorf's consumer portfolio. The growth came from face care, led by the expanded Thiamidol pigmentation line and the Epicelline anti-ageing launch, which shows premium dermocosmetic lines outgrowing mass body care.
L'Oreal's Dermatological Beauty division grew 9.8% like-for-like in 2024 and crossed EUR 7 billion, reaching a reported 25.5% share of its category. CeraVe brand sales crossed EUR 2 billion on international expansion into SAPMENA, China and Brazil, and La Roche-Posay became the world's third largest skincare brand across all channels.
Unilever's Beauty and Wellbeing division reported turnover of EUR 13 billion in 2024, 5.5% above 2023, with underlying sales up 6.5% split between 5.1% volume and 1.3% price. Skin care recorded mid-single-digit growth led by Vaseline, Dove and Pond's, so the gain came from units sold rather than from price.
Kenvue's Skin Health and Beauty segment net sales fell 3.2% to USD 4.2 billion for the fiscal year ended 29 December 2024, a decline of USD 138 million, with organic sales down 1.9% on volume decreases of 3.5% concentrated in the United States. American demand weakened in the same year European dermocosmetic lines grew.
The Procter & Gamble Company reported Beauty segment net sales of USD 15.2 billion for fiscal 2024, up 1% with organic sales up 3%. Olay, its largest skin care brand, generates approximately USD 3.6 billion in annual brand revenue, and the modest segment growth places the mass moisturiser tier behind the dermocosmetic tier.
Table of Contents
13 comprehensive chapters
1.1 Market Definition
1.2 Scope of the Study
1.3 Research Objectives
2.1 Research Approach
2.2 Data Sources
2.3 Market Estimation Approach
2.4 Forecast Assumptions
2.5 Research Limitations
3.1 Market Overview
3.2 Market Size and Forecast
3.3 Key Findings
3.4 Market Structure
4.1 Market Drivers
4.2 Market Challenges
4.3 Market Opportunities
4.4 Market Trends and Insights
5.1 Market Segmentation Overview
5.2 By Product Type
5.3 By Application
5.4 By Distribution Channel
5.5 By Ingredient Type
6.1 Asia Pacific
6.2 North America
6.3 Latin America
6.4 Europe
6.5 Middle East & Africa
6.6 Regional Market Comparison
7.1 Industry Developments
7.2 Industry Timeline
8.1 Market Structure and Competitive Positioning
8.2 Major Players
8.3 Strategic Developments
8.4 Key Competitive Factors
9.1 Unilever PLC
9.2 Beiersdorf AG
9.3 L'Oreal S.A.
9.4 The Procter & Gamble Company
9.5 Kenvue Inc.
10.1 Market Size and Growth Outlook
10.2 Regional Market Outlook
10.3 Future Market Trends
10.4 Key Risks to the Forecast
11.1 Growth Opportunities
11.2 Key Risks and Constraints
11.3 Strategic Considerations
13.1 Glossary of Terms
13.2 Abbreviations
13.3 Research References
Scope of the Report
Report coverage and methodology
Study Period
Base Year: 2025
Forecast Period: 2025 - 2033
Geographic Scope
Asia Pacific, North America, Latin America, Europe, Middle East & Africa
Companies Covered
Unilever PLC, Beiersdorf AG, L'Oreal S.A., The Procter & Gamble Company + more
Data Sources
Primary research, industry interviews, regulatory filings, company reports
Frequently Asked Questions
Common questions about this report
Ready to Get the Full Report?
Access comprehensive market insights, detailed analysis, and strategic recommendations to make informed business decisions.